JP2022540318A5 - - Google Patents

Info

Publication number
JP2022540318A5
JP2022540318A5 JP2021574234A JP2021574234A JP2022540318A5 JP 2022540318 A5 JP2022540318 A5 JP 2022540318A5 JP 2021574234 A JP2021574234 A JP 2021574234A JP 2021574234 A JP2021574234 A JP 2021574234A JP 2022540318 A5 JP2022540318 A5 JP 2022540318A5
Authority
JP
Japan
Prior art keywords
amino acid
nucleic acid
sequence
dna
acid construct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021574234A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022540318A (ja
JP7830129B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/055507 external-priority patent/WO2020250181A1/en
Publication of JP2022540318A publication Critical patent/JP2022540318A/ja
Publication of JP2022540318A5 publication Critical patent/JP2022540318A5/ja
Application granted granted Critical
Publication of JP7830129B2 publication Critical patent/JP7830129B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021574234A 2019-06-11 2020-06-11 標的遺伝子編集構築物およびそれを使用する方法 Active JP7830129B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962860186P 2019-06-11 2019-06-11
US62/860,186 2019-06-11
PCT/IB2020/055507 WO2020250181A1 (en) 2019-06-11 2020-06-11 Targeted gene editing constructs and methods of using the same

Publications (3)

Publication Number Publication Date
JP2022540318A JP2022540318A (ja) 2022-09-15
JP2022540318A5 true JP2022540318A5 (enExample) 2023-07-19
JP7830129B2 JP7830129B2 (ja) 2026-03-16

Family

ID=72178837

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021574234A Active JP7830129B2 (ja) 2019-06-11 2020-06-11 標的遺伝子編集構築物およびそれを使用する方法

Country Status (11)

Country Link
US (1) US20220235379A1 (enExample)
EP (1) EP3983541A1 (enExample)
JP (1) JP7830129B2 (enExample)
KR (1) KR20220019794A (enExample)
CN (1) CN114026240A (enExample)
AU (1) AU2020290790B2 (enExample)
BR (1) BR112021024828A2 (enExample)
CA (1) CA3141422A1 (enExample)
IL (1) IL288794A (enExample)
MX (1) MX2021015157A (enExample)
WO (1) WO2020250181A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7419168B2 (ja) * 2020-06-10 2024-01-22 株式会社東芝 改変型piggyBacトランスポゼースのポリペプチド、それをコードするポリヌクレオチド、導入キャリア、キット、細胞のゲノムに目的配列を組込む方法及び細胞製造方法
JP2023554504A (ja) 2020-12-16 2023-12-27 ユニバーシタット ポンペウ ファブラ プログラム可能なトランスポザーゼおよびその使用
CA3202411A1 (en) * 2020-12-16 2022-06-23 Marc Guell Cargol Therapeutic lama2 payload for treatment of congenital muscular dystrophy
CA3217426A1 (en) * 2021-05-14 2022-11-17 Alvaro GODINEZ Multiplexed unbiased nucleic acid amplification method
KR20240099249A (ko) * 2021-10-04 2024-06-28 포세이다 테라퓨틱스, 인크. 트랜스포사제 및 이의 용도
CA3244955A1 (en) * 2021-12-30 2023-07-06 Regel Therapeutics, Inc. Compositions for modulating the expression of the alpha 1 subunit of the voltage-gated sodium channel and their uses
WO2023141504A2 (en) * 2022-01-19 2023-07-27 Genomeminer, Inc. (Formally Tupac Bio, Inc.) Dcas9-integrase for targeted genome editing
KR20230122932A (ko) 2022-02-15 2023-08-22 주식회사 엘지에너지솔루션 이차전지 제조장치 및 이를 이용하는 이차전지 제조방법
CN116218904B (zh) * 2022-11-03 2025-04-15 国药中生生物技术研究院有限公司 一种可提高工程化细胞外泌体中特定核酸分子载量的方法及其应用
CN118185901B (zh) * 2022-12-12 2025-03-21 北京精缮生物科技有限责任公司 一种PBase蛋白、融合蛋白、核酸和基因整合系统及应用
CN120574802A (zh) * 2023-03-27 2025-09-02 北京星辰集因科技有限责任公司 一种分离的转座酶及其用途
CN121712899A (zh) * 2023-04-27 2026-03-20 伦斯勒理工学院 用于在真核细胞中准确插入dna序列的重组酶
WO2024246338A2 (en) 2023-06-01 2024-12-05 Integra Therapeutics Novel transposases and uses thereof
WO2025212757A2 (en) * 2024-04-03 2025-10-09 Buck Institute For Research On Aging Cas enabled targeted transposition
WO2026087488A1 (en) 2024-10-21 2026-04-30 Integra Therapeutics Gene editing tools and compositions for cell engineering
CN119842638A (zh) * 2025-01-20 2025-04-18 天津大学 融合酶突变体及其在氟代白藜芦醇合成中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1546322T1 (sl) * 2002-07-24 2011-05-31 Manoa Biosciences Inc Vektorji na osnovi transpozona in metode integracije nukleinskih kislin
US9783790B2 (en) * 2011-07-15 2017-10-10 The Johns Hopkins University Trichoplusia ni piggybac transposases with reduced integration activity
WO2015157611A2 (en) * 2014-04-11 2015-10-15 The Johns Hopkins University Improvements to eukaryotic transposase mutants and transposon end compositions for modifying nucleic acids and methods for production and use in the generation of sequencing libraries
EP3277805B1 (en) * 2015-03-31 2025-05-07 SOHM, Inc. Cas 9 retroviral integrase systems for targeted incorporation of a dna sequence into a genome of a cell
AU2016373365B2 (en) * 2015-12-14 2021-07-08 GenomeFrontier Therapeutics TW Co., Ltd. Transposon system, kit comprising the same, and uses thereof
WO2018175872A1 (en) * 2017-03-24 2018-09-27 President And Fellows Of Harvard College Methods of genome engineering by nuclease-transposase fusion proteins

Similar Documents

Publication Publication Date Title
US20230279391A1 (en) Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste)
US11840694B2 (en) Truncated CRISPR-Cas proteins for DNA targeting
AU2020290790B2 (en) Targeted gene editing constructs and methods of using the same
CN107109422B (zh) 使用由两个载体表达的拆分的Cas9的基因组编辑
CA3131284C (en) Compositions for linking dna-binding domains and cleavage domains
JP2023093658A5 (enExample)
JP7275043B2 (ja) 増大したhATファミリートランスポゾン媒介遺伝子導入ならびに関連する組成物、システムおよび方法
JP2021522783A5 (enExample)
US20110294217A1 (en) Dna nicking enzyme from a homing endonuclease that stimulates site-specific gene conversion
JP2025510586A5 (enExample)
EP3411056A1 (en) Compositions for linking dna-binding domains and cleavage domains
US11597947B2 (en) Gene editing method using virus
JP7843231B2 (ja) 遺伝子発現を増強させる哺乳動物配列への標的組込み
US20230287441A1 (en) Programmable insertion approaches via reverse transcriptase recruitment
CN102702331B (zh) 一对转录激活子样效应因子核酸酶及其编码基因与应用
JP2025516484A5 (enExample)
RU2022100100A (ru) Конструкции для направленного редактирования генов и способы с их применением
CN118086340A (zh) 微型碱基编辑器及其构建方法与应用
CN115279419A (zh) 用于基因组工程的组合物和方法
WO2026067648A1 (en) Type ii cas protein and uses thereof
US20160138047A1 (en) Improved polynucleotide sequences encoding tale repeats
WO2025054409A1 (en) Mutant tcbuster transposase with improved solubility
CN121931087A (zh) 新型碱基编辑器及其用途
TW202526012A (zh) 改良整合酶
Hryhorowicz et al. Programmable site-specific nucleases for target genome engineering